← Back to Search

Behavioural Intervention

TMS stimulation with X-Torp task for Alzheimer's Disease (TMS_AD Trial)

N/A
Waitlist Available
Research Sponsored by Ali Rezai
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months after completion study procedure
Awards & highlights

TMS_AD Trial Summary

This trial will test whether a combination of transcranial magnetic stimulation and cognitive training can reduce cognitive decline in patients with Alzheimer's disease.

Eligible Conditions
  • Alzheimer's Disease

TMS_AD Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months after completion of study procedure compared to screening
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months after completion of study procedure compared to screening for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Cognitive Performance
Secondary outcome measures
Brain MRI
Memory Performance

TMS_AD Trial Design

4Treatment groups
Experimental Treatment
Placebo Group
Group I: TMS-Stimulation with X-Torp taskExperimental Treatment1 Intervention
TMS with VR 1 experimental arm
Group II: TMS-Stimulation with MindMotion GoExperimental Treatment1 Intervention
TMS with VR 2 experimental arm
Group III: TMS-Sham with X-Torp taskPlacebo Group1 Intervention
TMS sham control with VR 1
Group IV: TMS-Sham with MindMotion GoPlacebo Group1 Intervention
TMS sham control with sham VR 2

Find a Location

Who is running the clinical trial?

Ali RezaiLead Sponsor
3 Previous Clinical Trials
64 Total Patients Enrolled
Marc Haut, PhDStudy ChairRockefeller Neuroscience Institute
Victor Finomore, PhDStudy DirectorRockefeller Neuroscience Institute

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Application of TMS Coupled With VR for Slowing the Rate of Cognitive Decline in Patients With Alzheimer's Disease
Ali Rezai 2019. "Application of TMS Coupled With VR for Slowing the Rate of Cognitive Decline in Patients With Alzheimer's Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04440891.
~0 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top